EMF Disturbance Monitors, Inc.

EMF Disturbance Monitors, Inc. is a United States-based medical device company founded in 2012. The company's mission is to revolutionize medical diagnostics by creating a new platform for the diagnosis of diseases in human and veterinary medicine. EMF utilizes newly patented technology to develop non-invasive medical diagnostic devices that analyze the unique "energy signature" of organs containing muscle and nerve cells.

Their innovative platform aims to diagnose congestive heart failure and cardiomyopathy in a single visit, offering a less expensive and non-invasive alternative to current methodologies. By measuring electromagnetic energy production in the human body, EMF enables the non-invasive diagnosis of multiple conditions that would have previously required invasive and multi-method approaches.

Currently, there is no information available regarding the latest investment and the associated investors. EMF operates within the Health Care and Pharmaceutical industries, signaling its commitment to driving innovation and advancement in the medical sphere from its United States headquarters.